{
    "pmcid": "10301551",
    "qa_pairs": {
        "What is the significance of the VYAWN motif in the context of the neutralizing nanobodies?": [
            "It is a known neutralizing epitope targeted by VH114.",
            "It is a novel epitope targeted by VH278.",
            "It is a linear epitope targeted by VH103.",
            "It is a conformational epitope targeted by VH105."
        ],
        "What potential advantage do nanobodies have over traditional antibodies in terms of safety?": [
            "They lack Fc regions, reducing the risk of ADE via Fc receptor-mediated pathways.",
            "They have a longer half-life, increasing their effectiveness.",
            "They can be easily modified to enhance their binding affinity.",
            "They are less expensive to produce, making them more accessible."
        ],
        "What technology was used to generate nanobodies targeting the SARS-CoV-2 spike protein?": [
            "Phage display technology",
            "CRISPR-Cas9 technology",
            "RNA interference technology",
            "Monoclonal antibody technology"
        ],
        "Which nanobodies were identified as effectively neutralizing SARS-CoV-2 by inhibiting the interaction between the RBD and hACE2?": [
            "VH114 and VH278",
            "VH103 and VH105",
            "VH319 and VH334",
            "VH359 and VH380"
        ],
        "Which variants of SARS-CoV-2 did the identified nanobodies show binding to, besides the Wuhan strain?": [
            "Delta and Omicron variants",
            "Alpha and Beta variants",
            "Gamma and Lambda variants",
            "Mu and Zeta variants"
        ]
    }
}